Company Filing History:
Years Active: 1991
Title: T Scott Edgington: Innovator in Blood Coagulation Inhibitors
Introduction
T Scott Edgington is a notable inventor based in La Jolla, California. He has made significant contributions to the field of blood coagulation through his innovative research and development of specific inhibitors.
Latest Patents
Edgington holds a patent for "Factor VII/VIIA active site inhibitors." This invention includes a class of compounds that inhibit the specific proteolytic activity of the bimolecular complex [TF:VII/VIIa], which initiates the blood coagulation systems. The patent discloses both reversible and irreversible inhibitors. Furthermore, it encompasses the use of these inhibitors as diagnostic reagents, analytical reagents, and therapeutic drugs. The compounds are based on a general formula designed for selective inhibition of [TF:VII/VIIa].
Career Highlights
Throughout his career, Edgington has focused on advancing medical science, particularly in the area of coagulation. His work has the potential to impact therapeutic approaches to blood-related disorders significantly.
Collaborations
One of his notable collaborators is Michael G Pepe, with whom he has worked closely on various projects related to his patent.
Conclusion
T Scott Edgington's contributions to the field of blood coagulation inhibitors highlight his innovative spirit and dedication to improving medical treatments. His patent represents a significant advancement in the understanding and management of blood coagulation systems.